1. Introduction
Using information and communication technology in pharmacy and healthcare opens up new ways to provide health services and helps solve the problem of a lack of health professionals [1]. Electronic health records and other new technologies, such as electronic health information systems, make it easier for pharmacists to find information about an exam or a drug therapy that was prescribed. By using these technologies, pharmacists can improve how drugs are used and also get the word out about telepharmaceutical services [2].
The National Association of Boards of Pharmacy defines it as “the provision of pharmacological treatment to patients at a distance using information and communication technology” [3]. Telepharmacy is a technology-based service that offers services such as prescription evaluation, medicine administration and compounding, drug therapy monitoring, and counseling [4,5,6]. Telepharmacy services include reviewing pharmaceutical orders, giving out drugs, counseling and evaluating patients, monitoring therapeutic drug use, and managing medication treatment [7].
Telepharmacy lets patients obtain their prescriptions and other pharmaceutical care services without having to go to a pharmacy [3,4]. It was found to reduce travel costs and save time, both of which are important barriers for patients in rural and faraway areas who need healthcare services, especially the disabled and elderly [4,8,9]. Telepharmacy also helps patients stay on their medicines by making them happier and more confident in the services they receive [10,11]. In addition, it has made pharmacists’ clinical roles more effective by giving them enough time for drug counseling in a more private setting [12,13].
The social distance between patients and healthcare providers has been enabled in many countries through the facilitation of remote pharmaceutical care services such as Internet services, virtual medical consultations, e-prescriptions, and home drug delivery [14]. With its origins in addressing healthcare access issues in rural regions, telepharmacy reaches its maximum use during global health crises [6]. Telepharmacy was quickly recognized as a tool capable of overcoming many of the pandemic’s challenges. The introduction of COVID-19 has accelerated the changes that would make telepharmacy a viable option. As healthcare providers and patients recognize the benefits of telepharmacy, there is a chance that it will continue even after the pandemic is over [15]. Ibrahim et al. reported that pharmacies with remote pharmacy services could help more patients with COVID-19 and confirm COVID-19 diagnosis more quickly than pharmacies without remote pharmacy services. They also reported that pharmacies with remote services were less likely than other pharmacies to make mistakes during medication dispensing [16]. Casey et al. found that the number of mistakes made when giving out medications decreased after a telepharmacy service was put in place [3].
There are several studies about the knowledge, perceptions, and readiness of pharmacists in community pharmacies in Saudi Arabia about telepharmacy. There are also studies about the knowledge, perception, and willingness of the public to use telepharmacy services. Nonetheless, there are no studies on the knowledge, perceptions, and readiness of hospital pharmacists about telepharmacy in Saudi Arabia, except in one conference abstract [17]. So, the present study included pharmacists who are working in hospital pharmacies. Therefore, the goal of this study was to find out what Saudi Arabian hospital pharmacists know, how they feel about telepharmacy services, and how ready they are to use them.
2. Materials and Methods
Between March and May 2020, a cross-sectional study was conducted among Saudi Arabian hospital pharmacists to assess their knowledge, perceptions, and readiness for telepharmacy. Pharmacists who worked in Saudi Arabian hospital pharmacies were included in the study. Pharmacists who worked in other settings such as community pharmacies and pharmaceutical companies were not included in the study. The subjects’ involvement was entirely voluntary, and there was no monetary incentive.
An online survey was used to obtain data from the participants, and it was based on a validated questionnaire used by a previous study [18]. The questionnaire was provided in English. After taking into account their experience and knowledge of the study subject, four pharmacy academicians reviewed the content validity of the questionnaire. After that, we sent the questionnaire to a few pharmacists as a pilot test to weed out any unnecessary or inadequate queries (the questionnaire was attached as a supplementary file).
The questionnaire was created using Google Forms as an online form. Data were collected on respondent demographics, employment statistics, hospital pharmacist knowledge about telepharmacy, pharmacist telepharmacy attitudes, and pharmacist telepharmacy preparedness. The online survey was sent to the pharmacists’ emails, and it was sent to other pharmacists using WhatsApp. After the pharmacists sent their responses, we checked the surveys to ensure that the surveys were filled out completely.
The sample size was calculated using the RAO sample size calculator, and using a margin error of 5%, confidence level of 95%, and response distribution of 50%. The minimum recommended size of our survey was 377 pharmacists.
The data were gathered using an Excel spreadsheet, and the descriptive results were presented in the form of numbers and percentages. After that, the Statistical Package for Social Science (SPSS) was used for the data analysis. Differences in pharmacists’ knowledge, perception, and readiness scores in relation to years of experience were assessed using an independent samples t-test. The level of significance was set at p < 0.05. The study was approved by the Research Ethics Committee/Health and Science Disciplines at Prince Sattam Bin Abdulaziz University with an approval number REC-HSD-134-2022.
3. Results
The survey was sent to five hundred pharmacists. A total of four hundred eleven individuals responded to the survey (the response rate was 82.2%). Males made up 54.01% of the respondents, with 71.29% of them being between the ages of 30 and 39 years, and the age of 24.33% of them was between 20 and 29 years. Most of the respondents had a bachelor’s degree in pharmacy (46.71%) or a PharmD degree (27.01%), and 20.44% of them had a master’s degree. Most of the responders (87.10%) received their most recent pharmacy degree or training in Saudi Arabia, and 5.11% of them received a pharmacy degree or training in the United States (Table 1).
Approximately 59.37% of pharmacists were employed in the Riyadh region, 9.49% in the Al-Qassim region, and 7.30% in the Makkah region (Figure 1).
Most of the pharmacists (62.53%) worked in urban areas, and 51.34% of them had less than five years of experience in hospital pharmacies. About 48.66% of the pharmacists were staff pharmacists, about 28.96% of them worked in an outpatient pharmacy, and about 44.28% of them worked in a primary healthcare institution. Most of the respondents had never provided pharmaceutical services via telepharmacy before (63.50%). More than half of the respondents (54.01%) stated that social media was their primary source of information, while 33.09% said that the Ministry of Health website was their primary source of information (Table 2).
Only 43.33% of the respondents agreed that telepharmacy is available in Saudi Arabia, 44.00% of them agreed that telepharmacy played a significant role during the global COVID-19 outbreak, 38.00% of the pharmacists agreed that telepharmacy provides better counseling in terms of privacy and the length of the session, and 38.67% of them agreed that telepharmacy solves the waiting time problem in most general hospitals.
About 36.67% of the hospital pharmacists agreed that telepharmacy is involved in adverse drug reaction monitoring and reporting, 36.67% of the respondents agreed that patients in rural areas can have more medication access and information via telepharmacy, and 39.33% of them agreed that telepharmacy services can extend hospital pharmacy services outside office hours that do not offer round-the-clock pharmacy services (Table 3).
Only 29.33% of hospital pharmacists agreed that telepharmacy improves patient medication adherence, 36.66% agreed that it improves patient access to medications in rural areas, and only 26.66% of them agreed that telepharmacy has a higher error rate for medication dispensing and filling compared to the traditional pharmacy. Furthermore, 34.00% of them said that telepharmacy increases the pharmacist’s workload and commitment, about 34.00% of the pharmacists agreed that telepharmacy saves patients money and time by eliminating the need for them to travel to healthcare facilities, and about 32.00% of them agreed that they are willing to share their personal information on the online database when using telepharmacy services.
About 33.33% of hospital pharmacists said that telepharmacy minimizes the cost to establish a pharmaceutical business in comparison to a regular pharmacy. About 33.33% of the hospital pharmacists agreed that patient consultation via telepharmacy is effective, and about 34.67% of them agreed that therapeutic drug monitoring via telepharmacy in rural areas is easily completed. Furthermore, 36.67% of pharmacists said that pharmacy schools should incorporate computer sciences and telepharmacy education programs to help with future telepharmacy use, and 33.33% of them agreed that telepharmacy helps to reduce pharmacist shortages (Table 4).
About 27.74% of the hospital pharmacists agreed that they are ready to work on telepharmacy projects in rural areas, even without an incentive, and 34.55% of them said that they are ready to work after office hours if needed. About 36.5% of pharmacists stated they are ready to provide pharmaceutical advice via two-way video consultation, such as phone calls, text messaging, or voice conversations using mobile devices. More than 39% of the pharmacists said that they are ready to teach patients how to use their drug delivery device through video consultation, and more than 37% of them agreed that they are ready to undergo training in ethics and legal issues related to telepharmacy.
About 35.28% of pharmacists said that they are prepared to tackle telepharmacy implementation in all clinical settings. Furthermore, about 37.96% of pharmacists stated that they are ready to utilize telepharmacy to increase patient safety and prevent prescription errors, and 39.17% of them said that they are ready to use telepharmacy to conduct medication reconciliation. More than 36% of the pharmacists agreed that they are ready to perform remote prescription-checking using an automated medication dispensing cabinet, and 36.98% of them said that they are ready to use applications and the Internet to receive refill orders and transfer prescriptions (see Table 5).
The differences in pharmacists’ knowledge, perception, and readiness scores in relation to years of experience are shown in Table 6. Regarding the knowledge, the correct answers were given 1 and the incorrect answers were given 0, and after that we calculated the average knowledge score. Regarding perceptions and readiness, strongly agree and agree were given 1; neutral, disagree, and strongly disagree were given 0; after that, we calculated the average perceptions and readiness scores. The average knowledge score, perceptions score, and readiness score were higher in pharmacists who had less than 5 years compared with pharmacists who had 5 or more years of experience (p value less than 0.05).
4. Discussion
In this study, hospital pharmacists in Saudi Arabia were asked about their knowledge, perceptions, and preparation for telepharmacy. Less than half of the pharmacists said that telepharmacy is available in Saudi Arabia. In general, there was uncertainty and variation in the response of the hospital pharmacists regarding their knowledge, which could be explained by the fact that it has not yet been fully developed and made widely available. Similarly, Elnaem et al. noted in their study that there was some uncertainty in the responses of future pharmacists in Malaysia [18]. Omran et al. reported that approximately 40% of Egyptian pharmacists were unfamiliar with the term telepharmacy [19]. Moreover, Tegegne et al. reported that only 32.4% of the pharmacy students in northwest Ethiopia had good knowledge of telepharmacy [20].
About 44% of pharmacists reported that telepharmacy played a big role during the COVID-19 outbreak around the world. Telepharmacy could overcome many of the challenges presented by the COVID-19 pandemic while still providing quality patient care [15]. Elnaem et al. stated that 93.8% of future Malaysian pharmacists agreed that telepharmacy played a big role during the COVID-19 outbreak around the world [18]. Unni et al. stated that the introduction of COVID-19 has hastened the changes required to make telepharmacy a viable option. They also stated that telepharmacy may continue even after the pandemic is over, as healthcare providers and patients recognize its benefits [15]. According to Ibrahim et al. pharmacies with remote pharmacy services could assist COVID-19 patients faster than pharmacies without remote pharmacy services [16]. Telepharmacy is a remote pharmaceutical care procedure. It has been used worldwide during the COVID-19 pandemic, with the aim of preserving the health of patients and professionals [21]. Dat et al. reported that about 87% of pharmacists have used telepharmacy in their pharmacy practice in response to the COVID-19 pandemic in Ho Chi Minh City, Vietnam. They also reported that the provision of medical information and remote medication counseling was an urgent need in the context of limited travel because of the COVID-19 pandemic [22].
Pharmacists are medical experts in charge of making sure that patients have access to the medications they require. Pharmacists must develop methods for the purchase, storage, and distribution of medications in order to accomplish this. This is in line with the pharmacist’s responsibility for addressing sufficient access to medications, one of the social determinants of health. When pharmacists provide care to a community that is underprivileged, rural, or remote, this duty becomes vital [23]. More than one-third of pharmacists in the current study said that telepharmacy can provide more drug availability and information to patients in remote places, and about half were uncertain. Ibrahim et al. [16] reported that many healthcare practitioners use telepharmacy services to improve patients’ access to pharmaceutical care. Furthermore, the Elnaem et al. study and the Poudel and Nissen study [8,18] showed that telepharmacy plays a significant role in improving drug access for patients in rural areas. Pathak et al. stated that telepharmacies are a suitable solution for expanding medication access and that using a telepharmacy would not have a negative impact on medication quality [24]. Omboni et al. reported that telepharmacy can provide access to healthcare services in remote communities [25].
When feasible, telepharmacy helps patients avoid waiting in a clinic with other sick patients, save time traveling, avoid work loss, and get themselves and their families healthy. Telepharmacy saves patients money and time by eliminating the need for them to visit healthcare facilities, according to 34.00% of pharmacists in the current study. Previous research has demonstrated that telepharmacy reduces travel costs and saves time, which are considered a major barrier to patients in rural and distant settings, particularly the disabled and elderly, receiving healthcare services [4,9]. More than 91% of pharmacists in Alanazi et al.’s study considered that employing a telepharmacy system may save them time and money [17]. The beneficial effect of telepharmacy in conserving patients’ resources was evaluated positively by study participants, with 91 percent agreement [18], according to Elnaem et al.
It is more difficult for people to fill prescriptions and obtain access to other essential services in rural regions due to a lack of pharmacies. Rural areas with a shortage of pharmacists experienced a reduction in turnaround time for clinical pharmacy services and an increase in medication errors linked to pharmacies. According to the current survey, about 33.33% of pharmacists believed that telepharmacy helps to minimize pharmacist shortages. Telepharmacy has already been shown to help with the provision and delivery of healthcare services for patients in rural locations or in situations when access to healthcare or pharmaceutical services is problematic for any reason [26,27,28]. In rural areas, where there is a shortage of pharmacists and clinicians, telepharmacy and telehealth clinical pharmacy services can fill the gap. Telepharmacy is a solution to the shortage of pharmacy employees, according to Baldoni et al. in which pharmaceutical services are provided remotely [29]. Furthermore, 75% of respondents in Elnaem et al.’s study agreed that telepharmacy may help alleviate the current pharmacist shortage [18]. Poudel and Nissen reported that telepharmacy addresses pharmacist shortages in rural areas and improves patient access to pharmaceuticals and pharmacy services [8].
The current study showed lower telepharmacy readiness among participants. Elnaem et al. reported that about 67% of the senior pharmacy students in a Malaysian public pharmacy school had high knowledge, and 68% of them showed high readiness levels. They also reported that factors such as a lack of incentive and an excessive workload were linked to participants’ telepharmacy preparedness [18]. Payment and reimbursement issues, as well as a lack of access to information technology infrastructure, were among the most important roadblocks, according to Ameri et al. [30]. According to Omran et al. the main barriers to telepharmacy practice included a lack of professional training, ethical concerns, and a formal practice framework [19]. Dat et al. reported that about 87.2% of the pharmacists in their study were ready to use telepharmacy [22]. Pharmacy colleges should incorporate telepharmacy practice models into their curricula in order to better prepare future pharmacists to provide telepharmacy services. Additionally, pharmacists’ knowledge and preparedness to utilize telepharmacy can be improved through the delivery of lectures, workshops, and conference attendance.
The present study showed that the average knowledge score, perceptions score, and readiness score were higher in pharmacists who had less than 5 years compared with pharmacists who had 5 or more years of experience. According to Fortnez et al.’s study, only younger pharmacist participants had higher levels of interest in and favorable views toward using telemedicine resources [31]. Ng and Sze reported that community pharmacists who are younger and have fewer years of experience in the workforce are more likely to have a favorable outlook toward the adoption of telepharmacy [32]. Telepharmacy services would appeal mainly to younger pharmacists, according to Ilki et al. [33]. Continuing professional education is a relevant venue to increase knowledge and promote a positive attitude towards telepharmacy, especially for older pharmacists.
The first limitation of the study was that it was based on an online survey, which could have resulted in selection bias. The study’s second limitation was that we have the contact information of several pharmacists who worked in several cities in Saudi Arabia, but we could not send emails and messages to all of the pharmacists who work in Saudi Arabia. Therefore, the present study included a small number of pharmacists, making the findings’ generalizability questionable. Further studies with larger sample sizes are needed to obtain more accurate or representative results.
5. Conclusions
From the results of this research, it is clear that there was uncertainty among hospital pharmacists regarding their level of telepharmacy knowledge, their attitude toward the practice, or their level of preparedness to incorporate it into their future pharmacy operations.
Conceptualization, methodology, and data analysis, N.J.A., Z.S.A., A.H.A., A.A.A. (Abdulmohsen A. Alturki), A.A.A. (Ahmad A. Alamer), A.H.B., A.M.A. (Alwaleed M. Almuaddi), S.M.A., M.B.A., A.K.A. and G.M.A.; writing—original draft preparation, N.J.A.; writing—review and editing, Z.S.A. and A.M.A. (Ahmed M. Alshehri); supervision, project administration, and funding acquisition, S.A.A., A.A.A. (Ahmed A. Albassam), Z.S.A. and N.J.A. All authors have read and agreed to the published version of the manuscript.
The study was approved by the Research Ethics Committee/Health and Science Disciplines at Prince Sattam bin Abdulaziz University with the approval number REC-HSD-134-2022.
Not applicable.
Data available on request due to restrictions.
This study is supported via funding from Prince Sattam bin Abdulaziz University project number (PSAU/2023/R/1444).
The authors declare no conflict of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 1. The regions where pharmacists work.
Demographic data of the respondents (n = 411).
| Variable | Category | Number | Percentage |
|---|---|---|---|
| Gender | Male | 222 | 54.01 |
| Female | 189 | 45.99 | |
| Age | 20–29 | 100 | 24.33 |
| 30–39 | 293 | 71.29 | |
| 40–49 | 16 | 3.89 | |
| More than 49 | 2 | 0.49 | |
| Education level | Bachelor’s degree | 192 | 46.71 |
| Pharm.D. | 111 | 27.01 | |
| Master’s degree | 84 | 20.44 | |
| Doctorate degree (Ph.D.) | 12 | 2.92 | |
| Other | 12 | 2.92 | |
| In which country have you earned your latest pharmacy degree or training? | Saudi Arabia | 358 | 87.10 |
| UK | 9 | 2.19 | |
| USA | 21 | 5.11 | |
| Australia | 6 | 1.46 | |
| Malaysia | 3 | 0.73 | |
| Egypt | 5 | 1.22 | |
| India | 3 | 0.73 | |
| Pakistan | 2 | 0.49 | |
| Other | 4 | 0.97 | |
| Nationality | Saudi Arabia | 400 | 97.32 |
| Others * | 11 | 2.68 |
* Others: Pharmacists who work in Saudi Arabia, but are not Saudis (For example, Pakistani, Indian, Jordanian, and Egyptian pharmacists).
Employment data of the respondents (n = 411).
| Variable | Category | Number | Percentage |
|---|---|---|---|
| What is your area of work? | Rural | 154 | 37.47 |
| Urban | 257 | 62.53 | |
| Years of experience in pharmacy | Less than 5 |
211 |
51.34 |
| What is your job position at your hospital pharmacy? | Staff pharmacist |
200 |
48.66 |
| What is your hospital pharmacy setting? | Out-patient pharmacy |
119 |
28.96 |
| What is the level of your healthcare institution? | Primary |
182 |
44.28 |
| Have you previously provided pharmaceutical services through telepharmacy? | Yes |
150 |
36.50 |
| Source of information | Local and international channels | 120 | 29.20 |
| Social media | 222 | 54.01 | |
| WHO website and social pages | 124 | 30.17 | |
| Scientific journals | 104 | 25.30 | |
| Ministry of Health website | 136 | 33.09 | |
| Colleagues | 119 | 28.95 | |
| Others | 135 | 32.85 |
Telepharmacy knowledge among pharmacists (n = 150).
| Item | Response | Number | Percentage |
|---|---|---|---|
| Telepharmacy is available in Saudi Arabia. | Yes | 65 | 43.33 |
| No | 13 | 8.67 | |
| Don’t know | 72 | 48.00 | |
| Information communication technology (ICT) knowledge is important for pharmacists in how to conduct telepharmacy. | Yes | 67 | 44.67 |
| No | 15 | 10.00 | |
| Don’t know | 68 | 45.33 | |
| Telepharmacy played a big role during the COVID-19 outbreak around the world. | Yes | 66 | 44.00 |
| No | 15 | 10.00 | |
| Don’t know | 69 | 46.00 | |
| Telepharmacy does require a strong Internet connection or high-performance technology. | Yes | 61 | 40.67 |
| No | 17 | 11.33 | |
| Don’t know | 72 | 48.00 | |
| Telepharmacy provides better counseling in terms of privacy and length of the session. | Yes |
57 |
38.00 |
| Telepharmacy solves the waiting time problem in most general hospitals. | Yes |
58 |
38.67 |
| Telepharmacy is also involved in adverse drug reaction monitoring and reporting. | Yes |
55 |
36.67 |
| Telepharmacy is conducted by drug information services during office hours and by emergency departments after office hours. | Yes |
55 |
36.67 |
| Patients from rural areas can have more medication access and information via telepharmacy. | Yes |
55 |
36.67 |
| Telepharmacy services can extend hospital pharmacy services outside office hours that do not offer round-the-clock pharmacy services. | Yes |
59 |
39.33 |
Telepharmacy perceptions among pharmacists (n = 150).
| Items | Strongly Disagree | Disagree | Unsure | Agree | Strongly Agree |
|---|---|---|---|---|---|
| Telepharmacy improves patient’s adherence to the medication. | 9 |
8 |
89 |
35 |
9 |
| Telepharmacy has a higher error rate for medication dispensing and filling compared to traditional pharmacy. | 5 |
14 |
91 |
32 |
8 |
| Telepharmacy enhances patient’s access to medications in rural areas. | 4 |
7 |
84 |
44 |
11 |
| Telepharmacy provides a complete privacy setting during the consultation period. | 3 |
10 |
86 |
40 |
11 |
| Telepharmacy increases pharmacist’s workload and commitment. | 3 |
9 |
87 |
37 |
14 |
| Telepharmacy helps patients save their money and travel time to reach the healthcare facilities. | 4 |
6 |
89 |
35 |
16 |
| I am willing to share my personal information on the online database when using telepharmacy services. | 5 |
11 |
86 |
37 |
11 |
| Telepharmacy minimizes the cost to establish a pharmaceutical business in comparison to the regular pharmacy. | 5 |
9 |
86 |
42 |
8 |
| Patient consultation via telepharmacy is effective. | 3 |
10 |
87 |
41 |
9 |
| Pharmacy schools should provide education programs on IT and telepharmacy to assist in the future utilization of telepharmacy. | 4 |
7 |
84 |
40 |
15 |
| Therapeutic drug monitoring via telepharmacy in rural areas is easily monitored. | 4 |
11 |
83 |
40 |
12 |
| Security is a greater concern in a remote site telepharmacy than in a traditional community pharmacy. | 4 |
7 |
81 |
42 |
16 |
| Telepharmacy helps to minimize the shortage of pharmacists. | 4 |
8 |
88 |
38 |
12 |
Telepharmacy readiness among pharmacists (n = 411).
| Items | Strongly Disagree | Disagree | Unsure | Agree | Strongly Agree |
|---|---|---|---|---|---|
| I am ready to work on telepharmacy projects in rural areas, even without an incentive. | 19 |
37 |
241 |
87 |
27 |
| I am ready to work after office hours if needed. | 15 |
20 |
234 |
108 |
34 |
| I am ready to conduct drug counseling via two-way video consultation. * | 10 |
20 |
231 |
120 |
30 |
| I am ready to teach patients how to use their drug delivery devices through video consultation. | 8 |
25 |
217 |
125 |
36 |
| I am ready to undergo training in ethics and legal issues related to telepharmacy. | 8 |
18 |
231 |
113 |
41 |
| I am ready to face the implementation of telepharmacy in all healthcare settings. | 8 |
22 |
236 |
106 |
39 |
| I am ready to conduct a home medication review (HMR) through telepharmacy. | 8 |
22 |
239 |
112 |
30 |
| I am ready to reduce the risk of medication errors among patients through telepharmacy. | 10 |
17 |
228 |
126 |
30 |
| I am ready to carry the increment of workload when conducting telepharmacy. | 10 |
27 |
223 |
109 |
42 |
| I am ready to conduct medication reconciliation via telepharmacy services. | 9 |
17 |
224 |
119 |
42 |
| I am ready to perform remote prescription-checking using an automated medication dispensing cabinet. | 8 |
21 |
231 |
115 |
36 |
| I am ready to use applications and the Internet to receive refill orders and transfer prescriptions. | 12 |
16 |
231 |
113 |
39 |
* Two-way video consultation such as telephone calls, text messages, or voice calls through mobile applications.
Differences in pharmacists’ knowledge, perception, and readiness scores in relation to years of experience.
| Years of Experience | Average Knowledge Score | p Value |
|---|---|---|
| Less than 5 | 0.42 | 0.02 |
| More than 5 years | 0.38 | |
| Years of experience | The average score for perceptions | p value |
| Less than 5 |
0.39 |
0.003 |
| Years of experience | The average score for readiness | p value |
| Less than 5 |
0.41 |
0.008 |
Supplementary Materials
The following supporting information can be downloaded at:
References
1. Kilova, K.; Peikova, L.; Mateva, N. Telepharmacy and opportunities for its application in Bulgaria. Pharmacia; 2021; 68, 333. [DOI: https://dx.doi.org/10.3897/pharmacia.68.e63517]
2. Pedersen, C.A.; Schneider, P.J.; Scheckelhoff, D.J. ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education—2015. Am. J. Health Syst. Pharm.; 2016; 73, pp. 1307-1330. [DOI: https://dx.doi.org/10.2146/ajhp160081]
3. Casey, M.M.; Sorensen, T.D.; Elias, W.; Knudson, A.; Gregg, W. Current practices and state regulations regarding telepharmacy in rural hospitals. Am. J. Health Syst. Pharm.; 2010; 67, pp. 1085-1092. [DOI: https://dx.doi.org/10.2146/ajhp090531]
4. Win, A.Z. Telepharmacy: Time to pick up the line. Res. Soc. Administ. Pharm.; 2017; 4, pp. 882-883. [DOI: https://dx.doi.org/10.1016/j.sapharm.2015.06.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26141501]
5. Keeys, C.; Kalejaiye, B.; Skinner, M.; Eimen, M.; Neufer, J.; Sidbury, G.; Buster, N.; Vincent, J. Pharmacist-managed inpatient discharge medication reconciliation: A combined onsite and telepharmacy model. Am. J. Health Syst. Pharm.; 2014; 71, pp. 2159-2166. [DOI: https://dx.doi.org/10.2146/ajhp130650] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25465589]
6. Le, T.; Toscani, M.; Colaizzi, J. Telepharmacy: A new paradigm for our profession. J. Pharm. Pract.; 2020; 33, pp. 176-182. [DOI: https://dx.doi.org/10.1177/0897190018791060] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30060679]
7. Margolis, A.; Young, H.; Lis, J.; Schuna, A.; Sorkness, C.A. A telepharmacy intervention to improve inhaler adherence in veterans with chronic obstructive pulmonary disease. Am. J. Health Syst. Pharm.; 2013; 70, pp. 1875-1876. [DOI: https://dx.doi.org/10.2146/ajhp120241]
8. Poudel, A.; Nissen, L.M. Telepharmacy: A pharmacist’s perspective on the clinical benefits and challenges. Integr. Pharm. Res. Pract.; 2016; 5, 75. [DOI: https://dx.doi.org/10.2147/IPRP.S101685]
9. Traynor, K. Telepharmacy services bring new patient care opportunities. Am. J. Health Syst. Pharm.; 2013; 70, pp. 565-566. [DOI: https://dx.doi.org/10.2146/news130025]
10. Friesner, D.; Scott, D.M. Exploring the formation of patient satisfaction in rural community telepharmacies. J. Am. Pharm. Assoc.; 2009; 49, pp. 509-518. [DOI: https://dx.doi.org/10.1331/JAPhA.2009.08110]
11. Rothwell, M.; Hogan, A. Clinical Pharmacists Connecting with Patients in Rural and Remote Towns via Telehealth; National Rural Health Alliance: Deakin, Australia, 2015.
12. Clifton, G.D.; Byer, H.; Heaton, K.; Haberman, D.J.; Gill, H. Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing. Am. J. Health Syst. Pharm.; 2003; 60, pp. 2577-2582. [DOI: https://dx.doi.org/10.1093/ajhp/60.24.2577] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14750497]
13. Lam, A.Y.; Rose, D. Telepharmacy services in an urban community health clinic system. J. Am. Pharm. Assoc.; 2009; 49, pp. 652-659. [DOI: https://dx.doi.org/10.1331/JAPhA.2009.08128]
14. Merks, P.; Jakubowska, M.; Drelich, E.; Świeczkowski, D.; Bogusz, J.; Bilmin, K.; Sola, K.F.; May, A.; Majchrowska, A.; Koziol, M. et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res. Soc. Adm. Pharm.; 2021; 17, pp. 1807-1812. [DOI: https://dx.doi.org/10.1016/j.sapharm.2020.05.033]
15. Unni, E.J.; Patel, K.; Beazer, I.R.; Hung, M. Telepharmacy during COVID-19: A Scoping Review. Pharmacy; 2021; 9, 183. [DOI: https://dx.doi.org/10.3390/pharmacy9040183] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34842823]
16. Ibrahim, O.M.; Ibrahim, R.M.; Al Meslamani, A.Z.; Al Mazrouei, N. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J. Telemed. Telecare; 2023; 29, pp. 18-27. [DOI: https://dx.doi.org/10.1177/1357633X20964347] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33059541]
17. Alanazi, A.; Albarrak, A.; Muawad, R. 5PSQ-184 Knowledge and attitude assessment of pharmacists toward telepharmacy in Riyadh City, Saudi Arabia. EAHP; 2021; 5, A146.
18. Elnaem, M.H.; Akkawi, M.E.; Al-Shami, A.K.; Elkalmi, R. Telepharmacy Knowledge, Perceptions, and Readiness among Future Malaysian Pharmacists Amid the COVID-19 Pandemic. Indian J. Pharm. Educ. Res.; 2022; 56, pp. 9-16. [DOI: https://dx.doi.org/10.5530/ijper.56.1.2]
19. Omran, S.; Elnaem, M.H.; Ellabany, N. Telepharmacy Knowledge, Attitude and Practice among Egyptian Pharmacists amid the COVID-19 Pandemic. J. Am. Coll. Clin. Pharm.; 2021; 4, 1643.
20. Tegegne, M.D.; Wubante, S.M.; Melaku, M.S.; Mengiste, N.D.; Fentahun, A.; Zemene, W.; Zeleke, T.; Walle, A.D.; Lakew, G.T.; Tareke, Y.T. et al. Tele-pharmacy perception, knowledge and associated factors among pharmacy students in northwest Ethiopia: An input for implementers. BMC Med. Educ.; 2023; 23, 130. [DOI: https://dx.doi.org/10.1186/s12909-023-04111-9]
21. Margusino-Framiñán, L.; Fernández-Llamazares, C.M.; Negro-Vega, E.; Tortajada-Goitia, B.; Lizeaga, G.; Mercadal-Orfila, G.; Almeida-González, C.; Morillo-Verdugo, R. Outpatients’ Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project. J. Multidiscip. Healthc.; 2021; 14, pp. 3621-3632. [DOI: https://dx.doi.org/10.2147/JMDH.S343528]
22. Dat, T.V.; Tran, T.D.; My, N.T.; Nguyen, T.T.H.; Quang, N.N.A.; Tra Vo Nguyen, M.; Hong Ngoc Vo, P.; Ho, T.T.; Manh Nguyen, C.; Thi Ngoc Nguyen, T. et al. Pharmacists’ Perspectives on the Use of Telepharmacy in Response to COVID-19 Pandemic in Ho Chi Minh City, Vietnam. J. Pharm. Technol.; 2022; 38, pp. 106-114. [DOI: https://dx.doi.org/10.1177/87551225221076327] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35571348]
23. Rovers, J.P.; Mages, M.D. A model for a drug distribution system in remote Australia as a social determinant of health using event structure analysis. BMC Health Serv. Res.; 2017; 17, 677. [DOI: https://dx.doi.org/10.1186/s12913-017-2629-x]
24. Pathak, S.; Haynes, M.; Qato, D.M.; Urick, B.Y. Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019. Prev. Chronic. Dis; 2020; 17, 200012. [DOI: https://dx.doi.org/10.5888/pcd17.200012]
25. Omboni, S.; Tenti, M. Telepharmacy for the management of cardiovascular patients in the community. Trends Cardiovasc. Med.; 2018; 29, pp. 109-117. [DOI: https://dx.doi.org/10.1016/j.tcm.2018.07.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30037524]
26. Kimber, M.B.; Peterson, G.M. Telepharmacy—Enabling technology to provide quality pharmacy services in rural and remote communities. J. Pharm. Pract. Res.; 2006; 36, pp. 128-133. [DOI: https://dx.doi.org/10.1002/j.2055-2335.2006.tb00588.x]
27. Margolis, S.A.; Ypinazar, V.A. Tele-pharmacy in remote medical practice: The Royal Flying Doctor Service Medical Chest Program. Rural Remote Health; 2008; 8, 937. [DOI: https://dx.doi.org/10.22605/RRH937]
28. Strasser, R. Rural health around the world: Challenges and solutions. Fam. Pract.; 2003; 20, pp. 457-463. [DOI: https://dx.doi.org/10.1093/fampra/cmg422]
29. Baldoni, S.; Amenta, F.; Ricci, G. Telepharmacy Services: Present Status and Future Perspectives: A Review. Medicina; 2019; 55, 327. [DOI: https://dx.doi.org/10.3390/medicina55070327]
30. Ameri, A.; Salmanizadeh, F.; Keshvardoost, S.; Bahaadinbeigy, K. Investigating pharmacists’ views on telepharmacy: Prioritizing key relationships, barriers, and benefits. J. Pharm. Technol.; 2020; 36, pp. 171-178. [DOI: https://dx.doi.org/10.1177/8755122520931442]
31. Fortúnez, P.R.; Franch-Nadal, J.; Pérez, J.A.F.; de Paz Orera, M.L.D.; Peña, M.D. Use of telemedicine in Spainperceptions of patients. Perspect. Health Inf. Manag.; 2018; 9, pp. 1-17.
32. Ng, W.L.; Sze, W.T. Perception and Attitude of Malaysian Community Pharmacists Towards the Implementation of Telepharmacy. Malays. J. Med. Health Sci.; 2022; 18, pp. 72-78. [DOI: https://dx.doi.org/10.47836/mjmhs.18.5.11]
33. Ilkić, J.; Obradović, D.; Georgiev, A.M.; Marinković, V.; Tadić, I. Implementation of Telepharmacy Services in Community Pharmacy—Pharmacists’ Perspective in Republic of Serbia. Pharmacog. Res.; 2023; 57, pp. 286-294. [DOI: https://dx.doi.org/10.5530/001954641895]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Telepharmacy is a technology-based service that provides promoted services such as counseling, medication administration and compounding, drug therapy monitoring, and prescription review. It is unclear whether hospital pharmacists possess the necessary knowledge, attitudes, and willingness to practice telepharmacy. The current study sought to investigate Saudi Arabian hospital pharmacists’ understanding, attitudes, and level of preparedness for telepharmacy services. A total of 411 pharmacists responded to the survey. Only 43.33% of the respondents agreed that telepharmacy is available in Saudi Arabia and 36.67% of the respondents agreed that patients in rural areas can have more medication access and information via telepharmacy. Only 29.33% of pharmacists agreed that telepharmacy improves patient medication adherence, and about 34.00% of the pharmacists agreed that telepharmacy saves patients money and time by eliminating the need for them to travel to healthcare facilities. This research found that hospital pharmacists were unsure of their level of knowledge, their attitude toward telepharmacy, and their willingness to incorporate it into their future pharmacy practices. To ensure that tomorrow’s pharmacists have the skills they need to provide telepharmacy services, telepharmacy practice models must be incorporated into the educational programs that prepare them.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Almalki, Ziyad S 1
; Alsawadi, Asmaa H 2 ; Alturki, Abdulmohsen A 1 ; Bakarman, Abdulaziz H 2 ; Almuaddi, Alwaleed M 1 ; Alshahrani, Saeed M 1 ; Alanazi, Meshari B 1 ; Alshehri, Ahmed M 1
; Albassam, Ahmed A 1 ; Alahmari, Abdullah K 1
; Alem, Ghada M 1 ; Aldosari, Saad A 1 ; Alamer, Ahmad A 1
1 Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
2 Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, Almaarefa University, Riyadh 13713, Saudi Arabia




